Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

about

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

Item

http://www.wikidata.org/entity/Q41545918

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

@en

type

Item

label

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

@en

prefLabel

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

@en

P1476

Acute and Chronic Noradrenergic Effects on Cortical Excitability in Healthy Humans.

@en

P2093

Asif Jamil

http://www.w3.org/2001/XMLSchema#string

Giorgi Batsikadze

http://www.w3.org/2001/XMLSchema#string

Hsiao-I Kuo

http://www.w3.org/2001/XMLSchema#string

Michael A Nitsche

http://www.w3.org/2001/XMLSchema#string

Min-Fang Kuo

http://www.w3.org/2001/XMLSchema#string

Walter Paulus

http://www.w3.org/2001/XMLSchema#string

P2860

Corticocortical inhibition in human motor cortex

Neuroplasticity regulation by noradrenaline in mammalian brain

Norepinephrine enables the induction of associative long-term potentiation at thalamo-amygdala synapses

Modulation of long-term synaptic depression in visual cortex by acetylcholine and norepinephrine.

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology.

Reboxetine: the first selective noradrenaline re-uptake inhibitor.

Neuromodulatory transmitter systems in the cortex and their role in cortical plasticity.

Clinical and research methods for evaluating cortical excitability.

Basic pathophysiological mechanisms in depression: what are they and how might they affect the course of the illness?

State of the art: Pharmacologic effects on cortical excitability measures tested by transcranial magnetic stimulation.

P304

634-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/IJNP/PYX026

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28430976

http://www.w3.org/2001/XMLSchema#string

P932

5574667

http://www.w3.org/2001/XMLSchema#string